Collective cancer invasion forms an integrin-dependent radioresistant niche
Open Access
- 28 October 2019
- journal article
- research article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 217 (1)
Abstract
Cancer fatalities result from metastatic dissemination and therapy resistance, both processes that depend on signals from the tumor microenvironment. To identify how invasion and resistance programs cooperate, we used intravital microscopy of orthotopic sarcoma and melanoma xenografts. We demonstrate that these tumors invade collectively and that, specifically, cells within the invasion zone acquire increased resistance to radiotherapy, rapidly normalize DNA damage, and preferentially survive. Using a candidate-based approach to identify effectors of invasion-associated resistance, we targeted β1 and αVβ3/β5 integrins, essential extracellular matrix receptors in mesenchymal tumors, which mediate cancer progression and resistance. Combining radiotherapy with β1 or αV integrin monotargeting in invading tumors led to relapse and metastasis in 40–60% of the cohort, in line with recently failed clinical trials individually targeting integrins. However, when combined, anti-β1/αV integrin dual targeting achieved relapse-free radiosensitization and prevented metastatic escape. Collectively, invading cancer cells thus withstand radiotherapy and DNA damage by β1/αVβ3/β5 integrin cross-talk, but efficient radiosensitization can be achieved by multiple integrin targeting.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (FR1155/8-1, 8-2 and 8-3 SPP-1190, DFG-FZ82)
- Netherlands Organisation for Scientific Research (918.11.626)
- European Research Council (617430-DEEPINSIGHT)
- Cancer Genomics Centre
- University of Texas MD Anderson Cancer Center
- Radboud University Medical Center
- Deutsche Forschungsgemeinschaft (GE 1188/3-1)
This publication has 106 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- α2β1 Integrin Promotes Chemoresistance against Doxorubicin in Cancer Cells through Extracellular Signal-regulated Kinase (ERK)Journal of Biological Chemistry, 2012
- β1 Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapyJournal of Clinical Investigation, 2012
- High-Level Expression of Wild-Type p53 in Melanoma Cells is Frequently Associated with Inactivity in p53 Reporter Gene AssaysPLOS ONE, 2011
- The DNA Damage Response: Making It Safe to Play with KnivesMolecular Cell, 2010
- Bioimpedance spectroscopy for the estimation of body fluid volumes in miceAmerican Journal of Physiology-Renal Physiology, 2010
- The Absence of Caveolin-1 Increases Proliferation and Anchorage- Independent Growth by a Rac-Dependent, Erk-Independent MechanismMolecular and Cellular Biology, 2009
- αvβ3 and αvβ5 integrins control glioma cell response to ionising radiation through ILK and RhoBInternational Journal of Cancer, 2008
- ECM overrides DNA damage-induced cell cycle arrest and apoptosis in small-cell lung cancer cells through β1 integrin-dependent activation of PI3-kinaseCell Death & Differentiation, 2006
- Integrin signalling during tumour progressionNature Reviews Molecular Cell Biology, 2004